Skip to content

ICU Medical ICUI Stock-Based Comp

Stock-Based Comp at other companies

Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
$10.2M+15.9%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$8.96M-1.3%
Baxter International logo
Baxter InternationalBAX
$10M0.0%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$58M+41.5%
TFX
TeleflexTFX
$6.74M+1.7%
Moog logo
MoogMOG.A

Other financials

Income statement

See full
Revenue$530.2M-12.3%
Gross profit$206.2M-1.8%
Operating income$13.6M+5.4%
Net income$30.1M+295%
EPS (diluted)$1.20+290%

Balance sheet

See full
Cash & equivalents$288.3M-0.5%
Total debt$1.4B-17.5%
Total equity$2.1B+6.3%
Total assets$4.0B-4.1%

Cash flow

See full
Operating cash flow$38.9M-24.2%
CapEx$11.3M-22.7%
Free cash flow$27.6M-24.8%

Valuation

See full
Market cap$3.51B-6.3%
Enterprise value$4.58B-10.6%
P/E75.3×+70.9×
P/S1.6×+0.1×

Profitability

See full
Gross margin37.9%+2.8pp
Operating margin2%-0.7pp
Net margin-0.3%-0.2pp
FCF margin4.2%-1.2pp

Returns & leverage

See full
Return on equity-0.4%-0.2pp
Debt / equity0.6×-0.2×
Current ratio2.3×-0.3×

Where this comes from

Reported directly by ICU Medical in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ICU Medical's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ICU Medical's stock-based comp?
ICU Medical (ICUI) reported stock-based comp of $14.01M in Q1 2026.
How has ICU Medical's stock-based comp changed year-over-year?
ICU Medical's stock-based comp increased by 15.0% year-over-year, from $12.18M to $14.01M.
What is the long-term trend for ICU Medical's stock-based comp?
Over 4 years (2021 to 2025), ICU Medical's stock-based comp has grown at a 19.5% compound annual growth rate (CAGR), from $27.34M to $55.76M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.